A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer
Clinical trial NCT03316586 · COMPLETED
Trial details
- NCT number
- NCT03316586
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-30
- Primary completion
- 2019-08-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.